Viewing Study NCT00633750


Ignite Creation Date: 2025-12-24 @ 4:58 PM
Ignite Modification Date: 2026-01-28 @ 1:53 PM
Study NCT ID: NCT00633750
Status: COMPLETED
Last Update Posted: 2012-09-05
First Post: 2008-03-11
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery
Sponsor: Vanderbilt-Ingram Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage I breast cancer View
None stage II breast cancer View
None stage IIIA breast cancer View
None stage IIIB breast cancer View